1AO6 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN |
1BJ5 | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID |
1BKE | A:4-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACID |
1BM0 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN |
1E78 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN |
1E7A | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL |
1E7B | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-580 | CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE |
1E7C | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE |
1E7E | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID) |
1E7F | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID) |
1E7G | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) |
1E7H | A:3-196; A:197-388; A:389-583 | HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID) |
1E7I | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID) |
1GNI | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9-OCTADECENOIC ACID (OLEIC ACID) |
1GNJ | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID) |
1H9Z | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN |
1HA2 | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S-(-) ENANTIOMER OF WARFARIN |
1HK1 | A:5-196; A:197-388; A:389-569 | HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) |
1HK2 | A:5-196; A:197-388; A:389-576 | HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) |
1HK3 | A:5-196; A:197-388; A:389-575 | HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) |
1HK4 | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID) |
1HK5 | A:3-196; A:197-388; A:389-584 | HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID) |
1N5U | A:2-196; A:197-388; A:389-584 | X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME |
1O9X | A:4-196; A:197-388; A:389-582 | HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN |
1TF0 | A:5-196; A:197-388; A:389-572 | CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMAN SERUM ALBUMIN |
1UOR | A:4-196; A:197-388; A:389-583 | X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN |
1YSX | A:389-584 | SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMIN COMPLEXED TO AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL-XL AND BCL-2 |
2BX8 | A:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE |
2BXA | A:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPANOIC ACID (CMPF) |
2BXB | A:207-378; A:389-582; B:207-378; B:389-582 | HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE |
2BXE | A:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL |
2BXF | A:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM |
2BXG | A:197-388; A:389-582; A:5-196; B:197-388; B:389-582; B:5-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN |
2BXH | A:5-196; A:197-388; A:389-561; B:5-196; B:197-388; B:389-561 | HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE |
2BXL | A:197-388; A:389-583; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 3,5-DIIODOSALICYLIC ACID |
2BXM | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN |
2BXN | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE |
2BXO | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE |
2BXP | A:197-388; A:389-583; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE |
2ESG | C:207-378; C:389-582 | SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN |
2I2Z | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND ASPIRIN |
2I30 | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND SALICYLIC ACID |
2VUE | A:197-388; A:389-579; A:5-196; B:197-388; B:389-575; B:5-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z,15E-BILIRUBIN-IX-ALPHA |
2XVQ | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE |
2XVU | A:5-196; A:197-388; A:389-579; B:5-196; B:197-388; B:389-571 | HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE |
2XW0 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE |
2XW1 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE |
2YDF | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID |
3A73 | A:2-196; A:197-388; A:389-584; B:2-196; B:197-388; B:389-584 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2 |
3B9L | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZT |
3B9M | A:197-388; A:389-584; A:3-196 | HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) AND SALICYLIC ACID |
3JRY | A:5-196; A:197-388; A:389-579; B:5-196; B:197-388; B:389-579 | HUMAN SERUM ALBUMIN WITH BOUND SULFATE |
3LU6 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1 |
3LU7 | A:5-196; A:197-388; A:389-582; B:4-196; B:197-388; B:389-582 | HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2 |
3LU8 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3 |
3TDL | A:3-196; A:197-388; A:389-584 | STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH DAUDA |
3UIV | A:3-196; A:197-388; A:389-584; H:3-196; H:197-388; H:389-584 | HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX |
4E99 | A:5-196; A:197-388; A:389-571 | HUMAN SERUM ALBUMIN COMPLEX WITH PERFLUOROOCTANE SULFONATE POTASSIUM |
4EMX | A:2-196; A:197-388; A:389-582; B:4-196; B:197-388; B:389-582 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE |
4G03 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN |
4G04 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN |
4HGM | B:4-196; B:197-388; B:389-492 | SHARK IGNAR VARIABLE DOMAIN |
4K71 | A:3-196; A:197-388; A:389-585; D:2-196; D:197-388; D:389-585 | CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR |
4L8U | A:2-196; A:197-388; A:389-584 | X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH 9 AMINO CAMPTOTHECIN |
4L9K | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN |
4L9Q | A:2-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE |
4LA0 | A:2-196; A:197-388; A:389-582; B:3-196; B:197-388; B:389-582 | X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE |
4LB2 | A:5-196; A:197-388; A:389-582; B:5-196; B:197-388; B:389-582 | X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN |
4LB9 | A:2-196; A:197-388; A:389-584 | X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH ETOPOSIDE |